Cytosolix jobs and careers
About Cytosolix
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.
Founded in 2017 by John Deacon.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $6.8M
Jobs at Cytosolix
No open positions right now. Explore more companies on TheJobsMap.